ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript
Source: SeekingAlpha
2025-12-01 20:03:24 ET
ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection December 1, 2025 4:15 PM EST...
Read the full article on Seeking Alpha
For further details see:
ProPhase Labs, Inc. (PRPH) Discusses Milestones in Cancer Diagnostics, Genomics Expansion, and COVID Accounts Receivable Collection Transcript
ProPhase Labs Inc.
NASDAQ: PRPH
PRPH Trading
-15.95% G/L:
$0.43 Last:
211,534 Volume:
$0.4641 Open:
PRPH Latest News
February 03, 2026 07:00:00 am
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart(TM) and Advances Crown Medical Collections Initiative
February 02, 2026 08:00:00 am
Join ProPhase Labs' Exclusive Live Investor Webinar and Q&A Session on February 3rd
PRPH Stock Data
$732,464
3,785,863
2.93%
8
289006%
Medical Diagnostics & Screening
Healthcare
US
Uniondale
